Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25052 | Lazertinib mesylate | 2247995-37-3 | ≧98.0% |  |
| Lazertinib is a an orally available third-generation, selective inhibitor of certain | ||||
| 25062 | GP130 modulator-1 | 2375779-31-8 | ≧98.0% |  |
| GP130 modulator-1 (compound A33) is agp130signaling pathway modulator. GP130 modulato | ||||
| 25063 | Seladelpar sodium salt | 3026272-26-1 | ≧98.0% |  |
| Seladelpar is a PPAR-delta agonist. | ||||
| 25065 | Ecopipam ( SCH 39166 ) | 112108-01-7 | ≧98.0% | _112108-01-7.png) |
| Ecopipam ( SCH 39166 ) is a Selective Dopamine Receptor D1/D5 Antagonist used in the | ||||
| 25078 | CFT1946 | 2882165-79-7 | ≧98.0% |  |
| CFT1946 is an investigational, orally bioavailable small molecule degrader of BRAF V6 | ||||
| 24058 | NST-628 | 3002056-30-3 | ≧98.0% |  |
| NST-628 is a potent pan-RAF-MEK molecular glue that prevents the phosphorylation and | ||||
| 25088 | Tonabersat ( SB-220453 ) | 175013-84-0 | ≧98.0% |  |
| Tonabersat, also known as SB-220453, is gap-junction modulator for the prevention of | ||||
| 25089 | Irpagratinib | 2230974-62-4 | ≧98.0% |  |
| Irpagratinib is an orally bioavailable, selective inhibitor of human fibroblast growt | ||||
| 25091 | Rilzabrutinib ( PRN1008 ) | 1575591-66-0 | ≧98.0% | _1575591-66-0.png) |
| Rilzabrutinib ( PRN1008 ) is an oral, reversible, covalent, small-molecule inhibitor | ||||
| 25094 | Nedisertib ( peposertib ) | 1637542-33-6 | ≧98.0% |  |
| Nedisertib, also known as M-3814, MSC2490484A, is an orally available inhibitor of DN | ||||
| 25095 | 5-Formyl-4-methyl-1H-indole-2-carbonitrile | 1857296-22-0 | ≧97.0% |  |
| 25096 | 5-Iodo-4-methyl-1H-indole-2-carbonitrile | 3007670-38-1 | ≧97.0% |  |